Epsium Enterprise Ltd. (EPSM) is planning to raise $6 million in an initial public offering on Wednesday, March 26th, IPO Scoop reports. The company will be issuing 1,300,000 shares at $4.00-$5.00 per ...

BofA raised the firm’s price target on Alkermes (ALKS) to $35 from $34 and keeps a Neutral rating on the shares. The firm’s higher target reflects ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

BofA raised the firm’s price target on VNET Group (VNET) to $17.30 from $14.50 and keeps a Buy rating on the shares. Management has guided to “a ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

Four-star-rated analyst Daniel Grosslight at Citi reiterated his Sell rating on Hims & Hers Health (HIMS) stock yesterday, ...

President Trump signed an executive order Tuesday that reaffirmed a priority from his first term: making health care prices public and easier for people to understand. The executive order promises ...

A federal judge has shut down compounding pharmacies from making cheaper versions of Eli Lilly’s weight loss and diabetes ...

Epsium Enterprise Ltd. (EPSM) plans to raise $6 million in an initial public offering on the week of March 17th, IPO Scoop reports. The company will be issuing 1,300,000 shares at a price of $4.00-$5.

A federal judge ended compounding pharmacies’ ability to make copies of the weight loss and diabetes drugs Zepbound and ...

According to a survey conducted by Intuit Credit Karma, 80% of Americans have seen a noticeable increase in the price of groceries in the last few years, especially after the pandemic. No matter ...